Entera Bio (ENTX) Proxy Filing summary

Executive summary

• Annual shareholder meeting scheduled for July 31, 2024, in Jerusalem, Israel.

• Shareholders can access proxy materials online and vote electronically, by phone, or in person.

Voting matters and shareholder proposals

• Election of Miranda Toledano and Yonatan Malca as Class I directors until the 2027 Annual Meeting.

• Ratification of a one-time compensation grant to CEO Miranda Toledano.

• Approval of revised compensation terms for non-executive board members.

• Amendment to the 2018 Equity Incentive Plan to increase shares issuable by 1,788,515.

• Approval of amended and restated compensation policy for directors and officers.

• Advisory vote on executive compensation and frequency of future advisory votes.

• Ratification of Kesselman & Kesselman (PwC) as independent auditors for fiscal year 2024.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals except for the frequency of advisory votes, where "one year" is recommended.